Engineered Cell Therapies and Antibodies

Synthetic biology will play an important role in advancing adoptive T cell therapy. Engineered receptors and genetic circuits can make cell-based therapies safer and more powerful. Cellular engineering and genome editing can further improve the T cell as a frame work for therapy.The adoptive transfer of genetically engineered T cells with cancer-targeting receptors has shown tremendous promise for eradicating tumors in clinical trials. This form of cellular immunotherapy presents a unique opportunity to incorporate advanced systems and synthetic biology approaches to create cancer therapeutics with Here novel functions.
 
Here are certain engineered cell therapy which are engineered .
  • Chimeric Antigen Receptor
  • Monoclonal Antibody
  • Adoptive Cell Transfer
  • Gene Therapy

Related Conference of Engineered Cell Therapies and Antibodies

September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Engineered Cell Therapies and Antibodies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in